Synlogic (SYBX) Tops Q4 EPS by 7c, Revenues Miss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Wall St futures pause after AI rally, focus on Mideast tensions
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Synlogic Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update
March 12, 2019 7:00 AM EDTEnded 2018 with approximately $123 million in cash and investments, which provides runway through 2020
Clinical trial readouts expected in mid-2019 from two Synthetic Biotic medicines and first IND application expected from Synlogics immuno-oncology platform in second half of 2019
Company will host a conference call and webcast at 8:00 am ET today
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Synlogic, Inc.... More
